INNO:CC News and Press, Innocan Pharma Corporation - Common Shares From 09/05/23

Innocan Pharma Announces Promising Results from Hair Care Cream Efficacy Test Canada NewsWire Innocan hair care cream efficacy trial observes enhanced hair growth in male and female participants in a 14day period. 91 % of participants reported stronger hair and 100% ...

Innocan Pharma Announces Clinical Study Results: Evidence of Reduced Osteoarthritis Pain in Dogs After Liposomal CBD Injection Canada NewsWire HERZLIYA, Israel and CALGARY, AB , Aug. 29, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OT...

Innocan Pharma Reports Q2 2023 Results Including US$2.706M Increase in Revenues Compared to Q2, 2022 Canada NewsWire US$3.121M Revenues for Q2, 2023 compared to US$415,000 for Q2 2022, representing an increase of 652% US$2.656M Gross Profit for Q2, 2023 compare...

Innocan Pharma Reports Q1 2023 Results including US$1.3M Increase in Revenues Compared to Q1 2022 Canada NewsWire USD 1.4M Gross Profit, compared to USD 78K last year USD 4.1M Cash Balance along the entire corporate structure USD 1.3M Increase in Revenu...

Innocan Pharma Reports Success in a Pre-Clinical Trial of a Liposomal-CBD Injection on a Paralyzed Goat Canada NewsWire HERZLIYA, Israel and CALGARY, Alberta , May 8, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company...

Innocan Pharma Reports Annual 2022 Results with USD 2.6M in Revenue Canada NewsWire HERZLIYA, Israel and CALGARY, Alberta , April 18, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") a pharmaceutical te...

Innocan Reports Novel Cannabinoid Delivery Platform Patent Application Canada NewsWire The application pertains to the development of a novel platform for loading Cannabinoids on Exosomes HERZLIYA, Israel and CALGARY, AB , April 3, 2023 /CNW/ -- Innoc...

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 23, 2023) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on developing innovative wellness products, announced today the successful results ...

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 17, 2023) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies and owner of a propri...

This is the first fully granted patent of Innocan in the United States The Patent covers Innocan's proprietary cannabis-based pain relief topical This serves as an indication of Innocan's growing intellectual property portfolio Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 1...